PALI
Palisade Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.09
+2.20%Jun 29, 2026, 12:30 UTC
Palisade Bio received FDA clearance of its Investigational New Drug application for PALI-2108.
Source:
NASDAQ · Healthcare · Biotechnology · US
Jun 29, 2026, 12:30 UTC